Hai cercato: XMD17-109
52 risultati sono stati trovati
~~A18L14A UHP SEC analysis of biosimilars~~
/it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/de_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/it_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/fr_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
product information
/m-it.vwr.com/it_IT/images/AP_A8360_Myco_1and2_Set.pdf
product information 1 Myco-1&2 Set Myco-1&2 Set (A8360) contains Myco-1 (A5222) Myco-2 (A5233) Product No. A8360 Description Treatment of Mycoplasma-infected Cells with Antibiotics The contamination of cells with mycoplasma is a very common proble...
product information
/m-ch.vwr.com/it_CH/images/AP_A8360_Myco_1and2_Set.pdf
product information 1 Myco-1&2 Set Myco-1&2 Set (A8360) contains Myco-1 (A5222) Myco-2 (A5233) Product No. A8360 Description Treatment of Mycoplasma-infected Cells with Antibiotics The contamination of cells with mycoplasma is a very common proble...
product information
/m-ch.vwr.com/de_CH/images/AP_A8360_Myco_1and2_Set.pdf
product information 1 Myco-1&2 Set Myco-1&2 Set (A8360) contains Myco-1 (A5222) Myco-2 (A5233) Product No. A8360 Description Treatment of Mycoplasma-infected Cells with Antibiotics The contamination of cells with mycoplasma is a very common proble...
product information
/m-ch.vwr.com/fr_CH/images/AP_A8360_Myco_1and2_Set.pdf
product information 1 Myco-1&2 Set Myco-1&2 Set (A8360) contains Myco-1 (A5222) Myco-2 (A5233) Product No. A8360 Description Treatment of Mycoplasma-infected Cells with Antibiotics The contamination of cells with mycoplasma is a very common proble...
product information
/m-it.vwr.com/it_IT/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
product information
/m-ch.vwr.com/de_CH/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
PEIpro Poster
/m-ch.vwr.com/fr_CH/images/Poster-PEIpro-Virus-PepTalk2018.pdf
PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....
PEIpro Poster
/m-it.vwr.com/it_IT/images/Poster-PEIpro-Virus-PepTalk2018.pdf
PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....
PEIpro Poster
/m-ch.vwr.com/it_CH/images/Poster-PEIpro-Virus-PepTalk2018.pdf
PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....
product information
/m-ch.vwr.com/fr_CH/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
product information
/m-ch.vwr.com/it_CH/images/AP_Myco_1_A5222_Myco_2_A5233_and_Myco_3_A5240.pdf
product information 1 Treatment of Mycoplasma-infected Cells with Antibiotics Myco-1 (A5222) Myco-2 (A5233) and Myco-3 (A5240) Description The contamination of cells with mycoplasma is a very common problem even though it often goes unnoticed sinc...
1 - 16 of 52